Axiom Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-385,870
| Closed | -$32.2M | – | 152 |
|
2016
Q2 | $32.2M | Sell |
385,870
-129,826
| -25% | -$10.8M | 0.93% | 40 |
|
2016
Q1 | $47.4M | Sell |
515,696
-23,120
| -4% | -$2.12M | 1.47% | 27 |
|
2015
Q4 | $54.5M | Sell |
538,816
-38,490
| -7% | -$3.89M | 1.76% | 21 |
|
2015
Q3 | $56.7M | Buy |
577,306
+241,306
| +72% | +$23.7M | 1.79% | 18 |
|
2015
Q2 | $39.3M | Buy |
+336,000
| New | +$39.3M | 1.13% | 42 |
|
2014
Q4 | – | Sell |
-815,410
| Closed | -$86.8M | – | 165 |
|
2014
Q3 | $86.8M | Sell |
815,410
-26,870
| -3% | -$2.86M | 2.15% | 10 |
|
2014
Q2 | $69.8M | Sell |
842,280
-61,450
| -7% | -$5.09M | 1.64% | 20 |
|
2014
Q1 | $64M | Sell |
903,730
-28,620
| -3% | -$2.03M | 1.53% | 21 |
|
2013
Q4 | $70M | Sell |
932,350
-44,750
| -5% | -$3.36M | 1.87% | 13 |
|
2013
Q3 | $61.4M | Buy |
977,100
+204,150
| +26% | +$12.8M | 1.96% | 12 |
|
2013
Q2 | $39.6M | Buy |
+772,950
| New | +$39.6M | 1.44% | 27 |
|